These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

608 related articles for article (PubMed ID: 26092263)

  • 1. Determinants of students' willingness to accept a measles-mumps-rubella booster vaccination during a mumps outbreak: a cross-sectional study.
    Donkers HW; Hautvast JL; Akkermans RP; Swaan CM; Ruijs WL; Hulscher ME
    BMC Public Health; 2015 Jun; 15():575. PubMed ID: 26092263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perceptions of mumps and MMR vaccination among university students in England: an online survey.
    Bolton-Maggs D; Conrad D; Keenan A; Lamden K; Ghebrehewet S; Vivancos R
    Vaccine; 2012 Jul; 30(34):5081-5. PubMed ID: 22705081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of Rubella vaccine in a rubella outbreak in Guangzhou city, China, 2014.
    Chang C; Mo X; Hu P; Liang W; Ma H; An Z; Liu J; Zheng H
    Vaccine; 2015 Jun; 33(28):3223-7. PubMed ID: 25989448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased measles-mumps-rubella (MMR) vaccine uptake in the context of a targeted immunisation campaign during a measles outbreak in a vaccine-reluctant community in England.
    Le Menach A; Boxall N; Amirthalingam G; Maddock L; Balasegaram S; Mindlin M
    Vaccine; 2014 Feb; 32(10):1147-52. PubMed ID: 24440207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody persistence in children aged 6-7years one year following booster immunization with two MMR vaccines applied by aerosol or by injection.
    Díaz Ortega JL; Castaneda D; Arellano Quintanilla DM; Martínez D; Trumbo SP; Fernández de Castro J
    Vaccine; 2017 May; 35(23):3116-3122. PubMed ID: 28457672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mumps Outbreak in a Highly Vaccinated University-Affiliated Setting Before and After a Measles-Mumps-Rubella Vaccination Campaign-Iowa, July 2015-May 2016.
    Shah M; Quinlisk P; Weigel A; Riley J; James L; Patterson J; Hickman C; Rota PA; Stewart R; Clemmons N; Kalas N; Cardemil C;
    Clin Infect Dis; 2018 Jan; 66(1):81-88. PubMed ID: 29020324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measles, mumps, rubella and varicella antibodies among international and domestic university students.
    Dyda A; Broome A; Rawlinson W; Mahimbo A; Saha A; Kefalas B; Seale H; Macintyre CR; Zwar N; Gidding HF; Heywood AE
    J Travel Med; 2024 Jan; 31(1):. PubMed ID: 38195239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].
    Stohrer-Draxl P; Amstad H; Grize L; Gassner M; Takken-Sahli K; Bourquin C; Braun-Fahrländer C
    Praxis (Bern 1994); 1999 Jun; 88(24):1069-77. PubMed ID: 10420798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of a Third Dose of MMR Vaccine for Mumps Outbreak Control.
    Cardemil CV; Dahl RM; James L; Wannemuehler K; Gary HE; Shah M; Marin M; Riley J; Feikin DR; Patel M; Quinlisk P
    N Engl J Med; 2017 Sep; 377(10):947-956. PubMed ID: 28877026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The active offering of measles, rubella and mumps vaccine in new mothers: the experience of health facilities in one of the Local Health Unit of Rome, Lazio, Italy].
    Santoro V; Pettinicchio V; Lancia A; Vazzoler C; De Luca F; Franco E
    Ig Sanita Pubbl; 2016; 72(6):589-597. PubMed ID: 28214912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles, mumps, rubella prevention: how can we do better?
    Kauffmann F; Heffernan C; Meurice F; Ota MOC; Vetter V; Casabona G
    Expert Rev Vaccines; 2021 Jul; 20(7):811-826. PubMed ID: 34096442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of Early Measles, Mumps, and Rubella Vaccination Among 6-14-Month-Old Infants During an Epidemic in the Netherlands: An Observational Cohort Study.
    Woudenberg T; van der Maas NAT; Knol MJ; de Melker H; van Binnendijk RS; Hahné SJM
    J Infect Dis; 2017 Apr; 215(8):1181-1187. PubMed ID: 28368471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MMR vaccination and disease elimination: the Finnish experience.
    Davidkin I; Kontio M; Paunio M; Peltola H
    Expert Rev Vaccines; 2010 Sep; 9(9):1045-53. PubMed ID: 20822347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel measles outbreak control strategy in the Netherlands in 2013-2014 using a national electronic immunization register: A study of early MMR uptake and its determinants.
    Nic Lochlainn LM; Woudenberg T; van Lier A; Zonnenberg I; Philippi M; de Melker HE; Hahné SJM
    Vaccine; 2017 Oct; 35(43):5828-5834. PubMed ID: 28923422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of measles, mumps and rubella among young adults, after 20 years of universal 2-dose MMR vaccination in Israel.
    Levine H; Zarka S; Ankol OE; Rozhavski V; Davidovitch N; Aboudy Y; Balicer RD
    Hum Vaccin Immunother; 2015; 11(6):1400-5. PubMed ID: 25891446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of medical and paramedical university students in Lebanon against measles, mumps, rubella and varicella: active measures are needed.
    Chamat S; Salameh P; Haddad N; Berry A; Chedid P; Bouharoun-Tayoun H
    J Infect Public Health; 2011 Aug; 4(3):125-34. PubMed ID: 21843858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study.
    Bae GR; Choe YJ; Go UY; Kim YI; Lee JK
    Vaccine; 2013 May; 31(24):2661-6. PubMed ID: 23602654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of measles after the introduction of the combined measles-mumps-rubella (MMR) vaccine in 2004 with focus on the laboratory data, 2016 to 2019 outbreak, Romania.
    Lazar M; Stănescu A; Penedos AR; Pistol A
    Euro Surveill; 2019 Jul; 24(29):. PubMed ID: 31339098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Practices for Measles-Mumps-Rubella Vaccination Among US Pediatric International Travelers.
    Hyle EP; Rao SR; Bangs AC; Gastañaduy P; Fiebelkorn AP; Hagmann SHF; Walker AT; Walensky RP; Ryan ET; LaRocque RC
    JAMA Pediatr; 2020 Feb; 174(2):e194515. PubMed ID: 31816033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resurgence risk for measles, mumps and rubella in France in 2018 and 2020.
    Béraud G; Abrams S; Beutels P; Dervaux B; Hens N
    Euro Surveill; 2018 Jun; 23(25):. PubMed ID: 29945697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.